G. Molnar

发表

Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.

V. Hruby, Yue Wang, T. Vanderah, 2015, Journal of medicinal chemistry.

Opioid agonist--tachykinin antagonist as a new analgesic with adjuvant anticancer properties.

Joanna Matalińska, A. Lipkowski, E. Varga, 2013, Folia neuropathologica.

Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury–associated peripheral sensory neuropathy via block of N- and T-type calcium channels

M. Khanna, R. Khanna, J. Streicher, 2018, Pain.

Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism

V. Hruby, A. Misicka, J. Streicher, 2021, Biomedicines.

Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan Ligands.

A. Mollica, J. Streicher, A. Stefanucci, 2023, ACS chemical neuroscience.

Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a Mu Opioid Receptor Agonist/Delta Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.

K. Houseknecht, J. Streicher, S. Ananthan, 2020, Journal of medicinal chemistry.

Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism

M. Heien, James Melvin, J. Streicher, 2022, Frontiers in Drug Discovery.

Discovery of epoxyqueuosine (oQ) reductase reveals parallels between halorespiration and tRNA modification

V. Bandarian, G. Molnar, R. McCarty, 2011, Proceedings of the National Academy of Sciences.

A modulator of the low-voltage activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.

Chunlong Ma, Jun Wang, M. Patek, 2020, Pain.

Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.

V. Hruby, Yue Wang, T. Vanderah, 2015, Journal of medicinal chemistry.